adminipi

ChargePoint Technology boosts US team to support regional growth

Apr 20, 2018

Powder containment and aseptic transfer valve specialist ChargePoint Technology, has appointed two new area managers to support the increased demand for its containment technologies and solutions throughout the US. Following the appointment of Chris Rombach as President of ChargePoint Inc in 2017 and the opening of the company’s second US office in San Francisco, ChargePoint has experienced rapid growth across North America, with the region now accounting for over 35% of total sales. Tyler Courtney and Silke Grainger have joined the team as the Midwest and Western area managers respectively, giving ChargePoint Technology dedicated coverage across all states within the ...

Read More

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

Apr 20, 2018

Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted Orphan Drug Designation (EMA/OD/013/18) for Abeona’s gene therapy program ABO-202 for the treatment of subjects with neuronal ceroid lipofuscinosis, also known as Batten Disease, a fatal lysosomal storage disease that primarily affects the nervous system in children.  ABO-202 is an adeno-associated virus developed to introduce a functional copy of the CLN1 gene into cells in order to restore the enzyme activity that is needed to ...

Read More

E Ink and Faubel Unveil the Med Label to Revolutionize the Clinical Trial Supply Chain

Apr 19, 2018

The Smart Label Simplifies and Shortens Expiry Updates Allowing for Considerable Time and Cost Savings E Ink® Holdings, “E Ink” (8069.TW), the leading innovator of electronic ink technology and Faubel & Co. Nachf. GmbH, a proven supplier to the pharmaceutical and chemical industry, announced the availability of the Faubel-Med® Label, a smart label for investigational medicinal products. The Med Label features E Ink’s low-voltage film technology, bringing display modules and new system designs to pharmaceutical packaging. The Med Label is a combination of an ePaper display and a booklet label that is integrated with radio-frequency identification (RFID) technology to allow ...

Read More

automatica – The Leading Exhibition for Smart Automation and Robotics

Apr 18, 2018

Date: 19th – 22nd June 2018 Location: Messe München, Messegelände, 81823 Munich, Germany Website: https://automatica-munich.com/   Discover automation technology solutions for your entire value chain Do you want to continuously improve your products? And manufacture them faster and more cost-effectively at the same time? automatica gives you valid answers to important questions: What do you need to remain competitive? How is the digital transformation affecting your production operation? And what will the workplace look like in the future? automatica is the leading marketplace for automated production. It features the world’s largest range of robotics, assembly and handling solutions, machine vision ...

Read More

Phoenix Molecular Designs Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND

Apr 18, 2018

MD-026 is the first RSK inhibitor to demonstrate potential disease-modifying properties in triple-negative breast cancer (TNBC)   Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women.   Under the terms of the collaboration agreement, STA will become a new manufacturing partner for PhoenixMD for their platform of kinase inhibitor drug candidates to treat a wide range of unmet ...

Read More